Sanofi pulls drug application
From Times Wire Services
Sanofi-Aventis withdrew its application to gain U.S. approval for a weight loss drug after a meeting at which government advisors rejected the treatment on safety grounds.
The French company said it would resubmit its Food and Drug Administration application for Acomplia later. The company is discussing with government regulators ways to improve its application.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
